Israel’s Vaxil Bio, developer of the ImMucin cancer vaccine, is the first Israeli biotech to list on Toronto’s TSX-Venture Exchange. Vaxil’s Isaac Maresky rang the 21st March opening bell at the Toronto Stock Exchange, along with Israeli Consul General DJ Schneeweiss and many Israeli flags.
http://www.cjnews.com/news/business/dj-schneeweiss-joins-israeli-biotech-company-in-ringing-tsx-bell